MONTREAL, QUEBEC -- (MARKET WIRE) -- October 20, 2006 -- Ecopia BioSciences Inc. (TSX: EIA) announced today a series of management changes. Mr. Gregory L. White, who joined Ecopia in September 2004 to implement and manage the drug development aspects of the Company, has been appointed Vice-President, Operations. In addition to continuing to oversee the development of our lead compound, ECO-4601, Mr. White will play a key role in business development and strategic alliances activities. Dr Jim McAlpine, Vice-President, Chemistry and Discovery, who was instrumental in the discovery and pre-clinical development of Ecopia's New Chemical Entities, including ECO-4601, will assume direct responsibility of the discovery-related activities including the ECO-4601's analog program, which we believe will lead to our second oncology drug candidate. Dr Emmanuel Zazopoulos, Vice-president, Operations, Drug Discoveries has left the Company to take on new challenges.
